Skip to main content
. 2014 Dec 23;59(1):475–481. doi: 10.1128/AAC.03950-14

FIG 3.

FIG 3

Summary of incidence of peripheral axonal degeneration seen in control and high-dose groups (20 rats/group; 10 rats/sex/group) at 1, 3, 6, and 9 months (includes a 3-month recovery sacrifice after 6 months of dosing). When observed, the severity of degeneration was minimal to mild (score of 1 or 2) on a 4-point scale.